DOI: 10.1055/s-00000034

Klinische Pädiatrie

References

Kang Z, Chen JJ, Yu Y et al.
Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response.

Clin Cancer Res 2011;
17: 3181-3192

Download Bibliographical Data

Search in:
Access: